bullish
Giant Biogene Pre-IPO - Thoughts on Valuation
234 Views19 Oct 2022 09:51
Giant Biogene Holding (GBH HK) aims to raise around US$500m in its Hong Kong IPO. In this note, we talk about valuations.
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 7-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Sunshine Insurance Group Pre-IPO - The Negatives - Lacks Growth26 Oct 2022
- Giant Biogene IPO - Reasonable Valuation but in Unreasonable Markets25 Oct 2022
- Sunshine Insurance Group Pre-IPO - The Positives - Steady Headline Growth25 Oct 2022
- Giant Biogene Pre-IPO - Peer Comparison - Might Need to Spend a Lot More Online18 Oct 2022
- Giant Biogene Pre-IPO - The Negatives - Co-Founders Have Already Cashed in US$1bn+04 Aug 2022
- Giant Biogene Pre-IPO - The Positives - Fast Growth and Juicy Margins03 Aug 2022
x